GRCL Stock Ownership Activity
GRACELL BIOTECHNOLOGIES-ADR 13F holders
No value investing guru has made any change to the GRACELL BIOTECHNOLOGIES-ADR (GRCL) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying GRCL now?
According to the latest SEC filing(s) GRACELL BIOTECHNOLOGIES-ADR (GRCL) has not been purchased by any super investor.
To see more about who is investing in GRACELL BIOTECHNOLOGIES-ADR (GRCL), please go to the GRCL ownership page.
2022 Q1
(1 result)
Current price: $10.25
69.68%
Reported price*: $6.04
2021 Q4
(1 result)
Current price: $10.25
69.68%
Reported price*: $6.04
2021 Q3
(1 result)
Current price: $10.25
26.10%
Reported price*: $13.87
2021 Q2
(1 result)
Current price: $10.25
21.15%
Reported price*: $13.00
2021 Q1
(1 result)
Current price: $10.25
33.44%
Reported price*: $15.40
5 of 5
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.